Back
ESC2025 Premium Access

Cholesterol efflux capacity and subclinical atherosclerosis: is its impact greater in early stages?

Session: Novel biomarkers for cardiovascular risk assessment
Topic: Biomarkers
Speaker: Doctor W. Skoza (Madrid, ES)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Warren Skoza

Spanish National Centre for Cardiovascular Research, Madrid (Spain)
0 follower

3 more presentations in this session

Incident CHD, residual risk and traditional cardiovascular risk factors in the community: role of lipid-inflammatory axis

Speaker: Doctor N. Arnold (Hamburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Association between genetic polymorphisms in multiple thrombosis-related genes and long-term prognosis in coronary artery disease patients: a large-scale cohort study

Speaker: Miss K. Zhang (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

Prognostic value of GDF-15 in patients with suspected myocardial infarction

Speaker: Doctor J. Lehmacher (Hamburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Novel biomarkers for cardiovascular risk assessment

Speakers: Doctor W. Skoza, Doctor N. Arnold, Miss K. Zhang, Doctor J. Lehmacher
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources